4:00 PM SIGN-IN • 4:30 PM - 6:00 PM

BANDOL 1 (NEW WYNN SPACE)

CE: Inflammatory Bowel Disease: A Panel Discussion on Clinical and Operational Strategies for Biologic Usage

Inflammatory bowel disease (IBD) is a chronic, incurable illness comprising ulcerative colitis and Crohn disease. Goals of treatment in IBD include achieving and maintaining remission, which is often accomplished by pharmacologic treatment. Recent advancements have the potential to provide patients with new options to better control their symptoms and progression of the disease. The specialty pharmacist is ideally situated to work with patients and their providers to select and monitor safe, effective, and cost-effective therapies that improve quality of life and optimize patient outcomes. This expert panel discussion will highlight strategies for managing IBD as well as review recently approved agents, updated treatment guidelines, recent clinical trial data on biologics and biosimilars, and real-world data on how specialty pharmacists are helping to manage this complex disease.

Speakers

Rolf Benirschke

Patrick Nichols

Christopher Owens

Asembia

200 Park Avenue, Suite 300 
Florham Park, NJ 07932

973.564.8004

asembia.com

info@asembiasummit.com

SIGN UP FOR SUMMIT UPDATES

Asembia's Specialty Pharmacy Summit is a PRIVATE EVENT. Asembia reserves the right to deny registration and refuse access at our absolute and sole discretion for any reason whatsoever.

© 2020 Asembia Specialty Pharmacy Summit, LLC. All rights reserved.

CONNECT WITH US

  • Asembia LinkedIn
  • Asembia Twitter
  • Asembia Instagram
  • Asembia Facebook
  • Asembia Videos
  • Asembia Photos
2021Summit_Logo_White.png